Validation of the WHO-defined 20% circulating blasts threshold for diagnosis of leukemic transformation in primary myelofibrosis

Ítems similars

• Normal karyotype in myelofibrosis: is prognostic integrity affected by the number of metaphases analyzed?
  per: Nicolosi, Maura, et al.
  Publicat: (2018)
• Marked elevation of serum lactate dehydrogenase in primary myelofibrosis: clinical and prognostic correlates
  per: Shah, Sahrish, et al.
  Publicat: (2017)
• Sex and degree of severity influence the prognostic impact of anemia in primary myelofibrosis: analysis based on 1109 consecutive patients
  per: Nicolosi, Maura, et al.
  Publicat: (2018)
• Leukemic transformation among 1306 patients with primary myelofibrosis: risk factors and development of a predictive model
  per: Vallapureddy, Rangit R., et al.
  Publicat: (2019)
• Revised cytogenetic risk stratification in primary myelofibrosis: analysis based on 1002 informative patients
  per: Tefferi, Ayalew, et al.
  Publicat: (2018)